Get the Stockscreener App
40.50
3.98%
1.55
Revolution Medicines Inc stock is traded at $40.50, with a volume of 1.71M.
It is up +3.98% in the last 24 hours and up +5.50% over the past month.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
See More
Previous Close:
$38.95
Open:
$39.73
24h Volume:
1.71M
Relative Volume:
0.78
Market Cap:
$7.57B
Revenue:
$29.52M
Net Income/Loss:
$-567.06M
P/E Ratio:
-11.07
EPS:
-3.66
Net Cash Flow:
$-551.11M
1W Performance:
+6.66%
1M Performance:
+5.50%
6M Performance:
+2.22%
1Y Performance:
-6.34%
1-Day Range:
$39.17
$41.11
1-Week Range:
$37.88
$41.11
52-Week Range:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Name
Revolution Medicines Inc
Sector
Industry
Phone
415-766-3638
Address
700 SAGINAW DR, REDWOOD CITY, CA
Compare RVMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
40.50 | 7.28B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-25 | Initiated | Truist | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Aug-15-25 | Initiated | Wells Fargo | Overweight |
| Jul-15-25 | Initiated | Goldman | Buy |
| Jul-16-24 | Reiterated | Needham | Buy |
| Jul-12-24 | Initiated | Barclays | Overweight |
| Jul-08-24 | Initiated | Jefferies | Buy |
| Apr-12-24 | Reiterated | Needham | Buy |
| Apr-10-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-11-24 | Initiated | Piper Sandler | Overweight |
| Jan-05-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-24 | Initiated | Wedbush | Outperform |
| Nov-16-23 | Initiated | Raymond James | Outperform |
| Feb-28-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-14-22 | Initiated | Needham | Buy |
| Oct-21-22 | Initiated | Oppenheimer | Outperform |
| May-20-22 | Initiated | BofA Securities | Neutral |
| Mar-01-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Aug-12-21 | Downgrade | Goldman | Buy → Neutral |
| May-18-21 | Initiated | Goldman | Buy |
| May-21-20 | Initiated | H.C. Wainwright | Buy |
| Mar-09-20 | Initiated | Cowen | Outperform |
| Mar-09-20 | Initiated | Guggenheim | Buy |
| Mar-09-20 | Initiated | JP Morgan | Neutral |
View All
Revolution Medicines Inc Stock (RVMD) Latest News
What machine learning models say about Revolution Medicines Inc.July 2025 Catalysts & AI Forecast for Swing Trade Picks - Newser
What’s the recovery path for long term holders of Revolution Medicines Inc.July 2025 Breakouts & AI Optimized Trade Strategies - Newser
Will Revolution Medicines Inc. Equity Warrant stock go up soonMarket Movers & High Accuracy Buy Signal Tips - Newser
Institutional scanner results for Revolution Medicines Inc.Portfolio Gains Report & Daily Technical Forecast Reports - Newser
Strategies to average down on Revolution Medicines Inc. Equity Warrant - Newser
Short interest data insights for Revolution Medicines Inc. Equity WarrantMarket Growth Summary & Risk Managed Trade Strategies - Newser
Revolution Medicines stock initiated with Buy rating at Truist Securities By Investing.com - Investing.com Canada
What analysts say about Revolution Medicines Inc. stockMarket Trend Review & High Return Stock Watch Alerts - خودرو بانک
Is Revolution Medicines Inc. exposed to currency risksTrade Entry Summary & Daily Stock Trend Reports - خودرو بانک
Tick level data insight on Revolution Medicines Inc. Equity Warrant volatilityForecast Cut & Weekly Consistent Profit Watchlists - Newser
Is Revolution Medicines Inc. forming a double bottomMarket Growth Summary & High Accuracy Swing Entry Alerts - خودرو بانک
How to escape a deep drawdown in Revolution Medicines Inc. Equity WarrantQuarterly Earnings Summary & Daily Oversold Bounce Ideas - Newser
Revolution Medicines Inc. Equity Warrant’s volatility index tracking explainedTreasury Yields & Daily Profit Focused Screening - Newser
Truist Initiates Revolution Medicines at Buy With $99 Price Target - MarketScreener
Intraday pattern recognizer results for Revolution Medicines Inc.Oil Prices & Precise Buy Zone Identification - Newser
Does Revolution Medicines Inc. Equity Warrant show high probability of rebound2025 Performance Recap & Real-Time Volume Analysis - Newser
Regression analysis insights on Revolution Medicines Inc. performanceJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - Newser
Can a trend reversal in Revolution Medicines Inc. lead to recoveryPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
Published on: 2025-09-04 23:56:51 - Newser
Using Bollinger Bands to evaluate Revolution Medicines Inc.2025 Price Momentum & Community Verified Trade Alerts - Newser
Multi factor analysis applied to Revolution Medicines Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - Newser
Revolution Medicines Inc. Equity Warrant stock outlook for YEARJuly 2025 Snapshot & Weekly Watchlist for Hot Stocks - Newser
How to recover losses in Revolution Medicines Inc. stockTake Profit & Fast Momentum Entry Tips - Newser
Revolution Medicines CFO Anders Jack makes notable stock trades. - AInvest
Will Revolution Medicines Inc. outperform tech stocksJuly 2025 Spike Watch & Reliable Breakout Forecasts - خودرو بانک
Published on: 2025-09-04 09:12:05 - Newser
Will Revolution Medicines Inc. Equity Warrant bounce back from current supportJuly 2025 Setups & High Conviction Investment Ideas - Newser
Revolution Medicines Inc. stock trendline breakdownEarnings Miss & Free Reliable Trade Execution Plans - Newser
Is Revolution Medicines Inc. Equity Warrant stock bottoming out2025 Major Catalysts & Capital Protection Trading Alerts - Newser
Why Revolution Medicines Inc. Equity Warrant stock attracts strong analyst attentionMarket Volume Summary & Long Hold Capital Preservation Tips - Newser
How to manage a losing position in Revolution Medicines Inc.Buy Signal & Weekly Stock Performance Updates - Newser
Key resistance and support levels for Revolution Medicines Inc.2025 Technical Overview & Stepwise Swing Trade Plans - Newser
Detecting price anomalies in Revolution Medicines Inc. Equity Warrant with AIExit Point & Verified High Yield Trade Plans - Newser
Is Revolution Medicines Inc. a turnaround storyJuly 2025 Spike Watch & Daily Technical Stock Forecast Reports - خودرو بانک
Visual analytics tools that track Revolution Medicines Inc. performancePortfolio Performance Report & Reliable Intraday Trade Plans - Newser
Is Revolution Medicines Inc. stock showing strong momentumWeekly Market Summary & Daily Technical Stock Forecast Reports - خودرو بانک
Revolution Medicines Inc. Equity Warrant stock trend forecastBond Market & Fast Entry Momentum Trade Alerts - Newser
Is Revolution Medicines Inc. meeting your algorithmic filter criteria2025 Stock Rankings & Scalable Portfolio Growth Ideas - Newser
Is Revolution Medicines Inc. Equity Warrant stock undervalued right now2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - خودرو بانک
What is Revolution Medicines Inc.’s valuation compared to sectorJuly 2025 Recap & Accurate Entry and Exit Point Alerts - خودرو بانک
What’s the RSI of Revolution Medicines Inc. Equity Warrant stockWeekly Stock Summary & AI Enhanced Trading Signals - خودرو بانک
Real time alert setup for Revolution Medicines Inc. Equity Warrant performanceJuly 2025 Earnings & Capital Efficiency Focused Ideas - Newser
Smart tools for monitoring Revolution Medicines Inc.’s price action2025 Price Momentum & Low Risk Entry Point Guides - Newser
Using economic indicators to assess Revolution Medicines Inc. Equity Warrant potentialJuly 2025 Momentum & Short-Term High Return Strategies - Newser
How high can Revolution Medicines Inc. stock goQuarterly Risk Review & Daily Chart Pattern Signal Reports - Newser
Detecting support and resistance levels for Revolution Medicines Inc.2025 Institutional Moves & AI Powered Buy and Sell Recommendations - Newser
Is Revolution Medicines Inc.’s ROE strong enoughJuly 2025 Review & Free Technical Confirmation Trade Alerts - خودرو بانک
Sentiment analysis tools applied to Revolution Medicines Inc. Equity WarrantQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - Newser
What’s the recovery path for long term holders of Revolution Medicines Inc. Equity WarrantWeekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
Volume spikes in Revolution Medicines Inc. Equity Warrant stock – what they meanExit Point & Weekly High Return Opportunities - Newser
Real time pattern detection on Revolution Medicines Inc. stockJuly 2025 Big Picture & Safe Entry Momentum Tips - Newser
Revolution Medicines Inc Stock (RVMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):